Account Information

  • My Account

    Manage all your subscriptions, update your address, email preferences and change your password.

  • Help Center

    Get answers to common service questions, ask the analyst or contact our customer service department.

  • My Stock Talk Profile

    Update your stock talk name and/or picture.


These contrarian stocks thrive in good markets and bad

These contrarian stocks thrive in good markets and badIn my new profit guide, I reveal a group of super-safe stocks that don’t behave like regular stocks during market downturns. In fact, these rock-solid beauties historically SKYROCKET and THRIVE during the worst of times. During the last three market busts, stocks in this contrarian sector soared 42%… 135%… and even 200%. Do yourself a favor. Check out my free profit guide today.


Stocks Rise as Inflation Optimism Offsets Trade Chaos

By John Persinos on May 23, 2018

Investors have navigated a tightrope this year, with a few painful drops along the way. Three of the five steepest one-day point declines in the entire 122-year history of the Dow Jones Industrial Average all occurred in 2018.

The largest ever drop in the Dow happened on February 5, 2018, when the index plunged 1,175.21 points due to fears of rising inflation and borrowing costs.

Stocks almost lost their footing again today, but the Federal Reserve came to the rescue. The Dow Jones Industrial Average, S&P 500 and Nasdaq all inched into the green, after the three indices spent most of the session in sharply negative territory. Release of Federal Reserve minutes today indicating a calm attitude about inflation helped pare losses in late trading. The session was volatile.

The Fed prevented a market rout today, but mounting dangers are too great to ignore. We’re due for additional big sell-offs, which are only worsened by algorithmic “machine trading.”

Remain wary of the bullish pronouncements of government officials and their media shills. All too often, reassuring platitudes uttered one day are directly contradicted in 24 hours (or sometimes in minutes). It’s headline risk… on steroids. In this uncertain climate, large-cap momentum stocks are particularly vulnerable.

Global growth is slowing, inflation is stirring, bond yields are rising, public and private debt around the world is mushrooming, “populist” insurrections threaten social stability, North Korea remains untamed, Russia has gone rogue, political scandals engulf the White House… shall I go on?

I’m not an alarmist by nature and I take a dim view of perma-bears and fear-mongers. However, it’s important for investors to face harsh realities when they actually arise.

The catalyst for today’s volatility was the realization that trade disputes between the U.S. and China won’t be resolved anytime soon.

Trump initially threatened to impose $50 billion in tariffs on Chinese goods. China retaliated with tariffs on U.S. products, especially agricultural goods produced in “red states” that voted for Trump in 2016. Trump responded by threatening an additional $150 billion in tariffs. This tit-for-tat has spooked markets.

Indeed, the international trade framework involving all regions, not just China and America, is devolving into chaos. Investors who thought otherwise have been partaking of the “hopium” pipe.

Hopium is a term that I like to use for unrealistic hope that’s pursued like a drug. This habit-forming investment behavior is dangerous to your portfolio.

Geopolitical risks worsen…

You can add Turkey and Italy to the list of global crises. Turkey’s currency is plummeting to record lows. Italian borrowing costs are soaring on worries that the incoming coalition will hike government spending and walk away from the country’s huge debt.

President Trump today threw more cold water on Treasury Secretary Steven Mnuchin’s previous comments that the trade war is “on hold.” Trump said the current negotiating track seemed “too hard to get done,” a day after telling reporters that he was unhappy with the talks.

Reports also surfaced today that the president’s trade negotiating team is at each other’s throats, as the hawks battle the doves. The U.S. seems to have no coherent industrial or trade policy, whereas China is positioning itself to dominate most of the world’s key industries for decades to come. The U.S. is girding for battle… with itself.

The planned June 12 summit between President Trump and North Korean leader Kim Jong-Un also is in serious doubt, as the two leaders engage in testy exchanges. After luring Trump with softer rhetoric, Kim is behaving as a hardliner again, in a tactic reminiscent of Lucy jerking the football away from Charlie Brown.

The global economy enjoyed brisk, synchronized growth in 2017 and investors had expected this growth to continue in 2018. However, much of this expansion was fueled by an increase in trade.

These anxieties were underscored Wednesday, with release of the flash IHS/Markit Eurozone Purchasing Managers’ Index (PMI), which showed the single-currency European economy slowing more sharply than expected. The PMI fell from 55.1 in April to 54.1 in May, hitting fresh 18-month lows. The expected reading was 56.

The PMI for May, together with the April reading, indicated a second consecutive quarter of growth in the euro zone of only 0.4%. An economic slowdown already is underway; a trade war would only exacerbate it.

Wall Street has been traversing a risky line. It won’t take much for a bad tumble.

Wednesday Market Wrap

  • DJIA: +0.21% or +52.40 points to close at 24,886.81
  • S&P 500: +0.32% or +8.85 points to close at 2,733.29
  • Nasdaq: +0.64% or +47.50 points to close at 7,425.96

 Wednesday’s Big Gainers

Biotech signs major licensing deal.

Luxury retailer’s earnings beat expectations.

Real estate broker enjoys booming housing market.

Wednesday’s Big Decliners

Analysts bullish on biotech.

Drug firm makes inroads in rare disease market. 

Tech firm’s earnings exceed consensus forecasts.

Letters to the Editor

“Is Japan’s recovery in jeopardy?” — Robert P.

In the years since Japan’s once fearsome economy peaked in 1989, the country has grappled with a host of problems, including wage growth that puts the country at a disadvantage compared to lower-cost competitors; a gargantuan public debt; a graying population; and the decline of its once-famous knack for technological innovation.

The latest data don’t bode well for Japan. In a report released today, the flash Markit/Nikkei Japan Manufacturing PMI fell to 52.5 in May, the lowest level since August 2017, from a final 53.8 in April.

Questions about slowing global economic growth? I’m here to answer your questions:

John Persinos is managing editor of Personal Finance and Radical Wealth Alliance, as well as chief investment strategist of Breakthrough Tech Profits.


You might also enjoy…


Boost Your Annual Income By As Much As $12,036

We’ve uncovered a unique income-boosting opportunity that allows you to collect up to $1,003 a month in extra government cash. 

This plan is available to everyone over the age of 18.

The amount you make isn’t dependent upon your marital status…

How much money you currently make…

Or even how much money you made in the past.

Best of all, because of the way Uncle Sam views the money that comes from this plan, your current—or future—Social Security benefits won’t be affected, either. 

There’s still time to get your name on the list for the next check run. 

I’ll show you how here.

Stock Talk — Post a comment Comment Guidelines

Our Stock Talk section is reserved for productive dialogue pertaining to the content and portfolio recommendations of this service. We reserve the right to remove any comments we feel do not benefit other readers. If you have a general investment comment not related to this article, please post to our Stock Talk page. If you have a personal question about your subscription or need technical help, please contact our customer service team. And if you have any success stories to share with our analysts, they’re always happy to hear them. Note that we may use your kind words in our promotional materials. Thank you.

You must be logged in to post to Stock Talk OR create an account.

Create a new Investing Daily account

  • - OR -

* Investing Daily will use any information you provide in a manner consistent with our Privacy Policy. Your email address is used for account verification and will remain private.